Books > Medicine > Pre-clinical medicine: basic sciences > Medical genetics
|
Buy Now
Regulation of Genome Editing in Human iPS Cells - A Comparative Legal Analysis of National Regulatory Frameworks for iPSC-based Cell/Gene Therapies (Hardcover, 1st ed. 2022)
Loot Price: R3,954
Discovery Miles 39 540
|
|
Regulation of Genome Editing in Human iPS Cells - A Comparative Legal Analysis of National Regulatory Frameworks for iPSC-based Cell/Gene Therapies (Hardcover, 1st ed. 2022)
Expected to ship within 12 - 17 working days
|
The book provides a concise overview of currently applicable
regulatory frameworks of states which are among the world leaders
in research and development (R&D) of cell and gene therapies.
Developments in genome editing are expected to lead to new
possibilities for the treatment of hereditary diseases in humans.
The treatment of such often severe but hitherto uncurable diseases
can be based on genome-edited induced pluripotent stem cells (iPS
cells). Such treatments constitute combined cell/gene therapies.
These therapies need to be governed by a regulatory framework which
ensures quality, safety, and efficacy of the relevant therapeutic
products. On the other hand, such regulations may retard product
approval and impede R&D. Accordingly, national regulations for
therapies based on genome-edited iPS cells are an important and, as
the case may be, decisive factor for both researchers and industry
regarding their decision where to locate their R&D activities.
Therefore, regulatory frameworks impact significantly on the
competitiveness of states and their economies. This is why a
comparative analysis of laws and regulations of different countries
matters. Such a comparative legal analysis provides an important
insight into regulatory concepts which, in turn, may inspire
adjustments of, or amendments to, domestic legal regimes. For this
purpose, experts present country reports on France, Germany, Japan,
South Korea, Switzerland, and the USA. The reports on France and
Germany also refer to the parameters and implications arising from
pertinent EU law. This contributed volume is aimed at researchers,
but also at, e.g., legal scholars, lawmakers, regulators, and
political decision makers.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.